Drug Type Radiolabeled antibody, Therapeutic radiopharmaceuticals |
Synonyms Monoclonal antibody MX-DTPA BrE-3 |
Target |
Action inhibitors |
Mechanism MUC1 inhibitors(Mucin-1 inhibitors), Ionising radiation emitters |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization- |
Active Organization- |
Inactive Organization- |
License Organization- |
Drug Highest PhasePendingPhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Breast Cancer | Phase 1 | United States | - | - |